Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Metastatic Neuroendocrine Tumors
NCT02678780Phase 2Completed
- Sponsor
- Spanish Group of Neuroendocrine Tumors
- Start
- Oct 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of lenvatinib in Pancreatic neuroendocrine tumor (PanNET), Gastrointestinal neuroendocrine tumor, sponsored by Spanish Group of Neuroendocrine Tumors. Started Oct 2015; status: completed.
02
Drugs
lenvatinib
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)Gastrointestinal neuroendocrine tumor
Beyond the preview
Go deeper on NCT02678780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678780.